Opportunity Information: Apply for CDC RFA GH15 1588
Apply for CDC RFA GH15 1588
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Support the Mandate of the Ministry of Health and Social Welfare in the United Republic of Tanzania to Centrally Coordinate National Blood Transfusion Services in order to Ensure an Adequate and Safe Blood Supply under PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Oct 1, 2014 and posted on Oct 1, 2014.
- Applicants must submit their applications by Dec 7, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $5,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The National Blood Transfusion Service (NBTS) is the only institution mandated by the Government of Tanzania (Mainland) to carry out blood transfusion services in the country. It was established in 2004 with the goal of ensuring safe and sufficient blood supply for the country. Prior to 2004, blood was obtained solely from family replacement donors at fragmented hospital based transfusion units that lacked standardization of procedures. The Policy guidelines on blood transfusion in (2006) recommended a shift from hospital based transfusion service to centralized system which would later be semi autonomous and independent. This system ensures standardization with improved quality of blood supply and thus less transmission of HIV and other transfusion transmissible infections (TTIs). It also ensures that the same standard operating procedures (SOPs) are used nationally in the various blood transfusion centers. It is therefore necessary for this work to be coordinated by NBTS under the MOHSW. From 2005 to 2014, there have been two, five year cooperative agreements between CDC and NBTS.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity (CDC RFA GH15-1588) is a PEPFAR-supported cooperative agreement from the U.S. Centers for Disease Control and Prevention (CDC) focused on Tanzania Mainland. Its central aim is to strengthen Tanzania's nationally coordinated blood transfusion system so that health facilities that transfuse patients can reliably access an adequate supply of safe blood and blood products. The work is designed to reinforce the Ministry of Health and Social Welfare (MOHSW) mandate by supporting the National Blood Transfusion Service (NBTS) as the country-level body responsible for coordinating blood transfusion services under a centralized model.
The background driving the opportunity is the shift Tanzania made away from a fragmented, hospital-based system that relied heavily on family replacement donors. Before NBTS was established in 2004, many facilities operated transfusion units with limited standardization, which created quality and safety risks, including the potential for higher transmission of HIV and other transfusion-transmissible infections (TTIs). National policy guidance issued in 2006 recommended moving to a centralized system to standardize procedures and improve quality nationwide. Under this FOA, CDC continues its longer-term partnership with NBTS, following two previous five-year cooperative agreements spanning roughly 2005 to 2014, to further institutionalize and strengthen the centralized approach.
Over a five-year project period, the FOA expects progress in four main outcome areas. First, it targets an improved supply of safe blood and blood products at transfusion facilities by increasing the number of safe repeat voluntary donors and expanding the production of blood components, which supports more appropriate clinical use than relying primarily on whole blood. Second, it aims to improve the overall quality of blood and blood products by growing and maintaining a safer donor pool and strengthening adherence to blood safety and quality standards across the system. Third, it sets a concrete systems benchmark: achieving accreditation for all six zonal blood transfusion centers, reflecting improved compliance with recognized blood safety standards and more consistent quality management practices. Fourth, it emphasizes ownership and sustainability, seeking stronger staff retention within NBTS and increased funding for the program from non-PEPFAR sources so that the national service is less dependent on external support over time.
Administratively, the opportunity is a discretionary funding announcement using a cooperative agreement mechanism, which typically means substantial involvement by the CDC in collaboration, technical direction, and monitoring during implementation. It falls under CFDA 93.067 (Global AIDS) and anticipated a single award. The announcement listed an award ceiling of $5,000,000, no cost sharing or matching requirement, and an eligibility profile that effectively centers on NBTS as the government-mandated institution for these services in Tanzania Mainland. The opportunity was posted October 1, 2014, with an original and final closing date of December 7, 2014, and was archived January 6, 2015. For access issues with the full announcement, CDC directed applicants to its Procurement and Grants Office Technical Information Management Section via pgotim@cdc.gov or phone at 770-488-2700.
Frequently Asked Questions (FAQs)
1. What is CDC RFA GH15-1588?
CDC RFA GH15-1588 is a PEPFAR-supported cooperative agreement funding opportunity from the U.S. Centers for Disease Control and Prevention (CDC). It focuses on Tanzania Mainland and supports work to strengthen the country s nationally coordinated blood transfusion system.
2. What is the main goal of this grant opportunity?
The central aim is to strengthen Tanzania s nationally coordinated blood transfusion system so health facilities that transfuse patients can reliably access an adequate supply of safe blood and blood products.
3. Which country and geography does the opportunity cover?
This opportunity is focused on Tanzania Mainland.
4. What program or initiative supports this cooperative agreement?
The cooperative agreement is supported by PEPFAR and is listed under CFDA 93.067 (Global AIDS).
5. What organizations are specifically referenced in the opportunity?
The opportunity is designed to reinforce the Ministry of Health and Social Welfare (MOHSW) mandate by supporting the National Blood Transfusion Service (NBTS), which is the country-level body responsible for coordinating blood transfusion services under a centralized model.
6. Why is CDC funding this work (what problem is it addressing)?
The funding is driven by Tanzania s shift away from a fragmented, hospital-based transfusion system that relied heavily on family replacement donors. Before NBTS was established in 2004, many facilities operated with limited standardization, creating quality and safety risks, including potentially higher transmission of HIV and other transfusion-transmissible infections (TTIs).
7. What system change is this opportunity trying to strengthen?
It supports a centralized national blood transfusion system intended to standardize procedures and improve quality nationwide, consistent with national policy guidance issued in 2006.
8. What is the project period for this funding opportunity?
The FOA describes expectations over a five-year project period.
9. What are the main outcome areas expected over the five-year period?
The FOA expects progress in four main outcome areas: (1) improved supply of safe blood and blood products at transfusion facilities, (2) improved overall quality of blood and blood products, (3) accreditation for all six zonal blood transfusion centers, and (4) stronger ownership and sustainability through improved staff retention and increased non-PEPFAR funding.
10. How does the FOA propose improving the supply of safe blood and blood products?
It targets increased availability by increasing the number of safe repeat voluntary donors and expanding the production of blood components, which supports more appropriate clinical use than relying primarily on whole blood.
11. How does the FOA propose improving quality and safety?
It emphasizes growing and maintaining a safer donor pool and strengthening adherence to blood safety and quality standards across the system.
12. What does accreditation mean in the context of this opportunity?
The FOA includes a systems benchmark of achieving accreditation for all six zonal blood transfusion centers, reflecting stronger compliance with recognized blood safety standards and more consistent quality management practices.
13. How many zonal blood transfusion centers are included in the accreditation target?
The accreditation target is for all six zonal blood transfusion centers.
14. What does the FOA mean by ownership and sustainability?
Ownership and sustainability in this FOA focuses on stronger staff retention within NBTS and increased funding for the program from non-PEPFAR sources, reducing reliance on external support over time.
15. What type of funding mechanism is used?
This is a discretionary funding announcement using a cooperative agreement mechanism.
16. What does a cooperative agreement imply about CDC s role?
A cooperative agreement typically means substantial CDC involvement during implementation, including collaboration, technical direction, and monitoring.
17. What is the CFDA number associated with this opportunity?
The opportunity is listed under CFDA 93.067 (Global AIDS).
18. How many awards were anticipated?
The announcement anticipated a single award.
19. What was the maximum funding amount (award ceiling)?
The award ceiling listed in the announcement was $5,000,000.
20. Is cost sharing or matching required?
No. The announcement stated there is no cost sharing or matching requirement.
21. Who is eligible to apply based on the information provided?
The eligibility profile effectively centers on NBTS as the government-mandated institution responsible for coordinating blood transfusion services in Tanzania Mainland.
22. When was the opportunity posted?
The opportunity was posted on October 1, 2014.
23. What were the closing dates for applications?
The original closing date and the final closing date were both December 7, 2014.
24. When was the opportunity archived?
The opportunity was archived on January 6, 2015.
25. What is the historical context of CDC support for NBTS mentioned in the announcement?
The FOA continues a longer-term CDC partnership with NBTS and follows two previous five-year cooperative agreements spanning roughly 2005 to 2014, aimed at institutionalizing and strengthening the centralized approach.
26. What should someone do if they cannot access the full announcement?
CDC directed applicants with access issues to contact its Procurement and Grants Office Technical Information Management Section via email at pgotim@cdc.gov or by phone at 770-488-2700.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Pregnancy in Women with Disabilities (R21)
Previous opportunity: Pregnancy in Women with Disabilities (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1588
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1588) also looked into and applied for these:
| Funding Opportunity |
|---|
| Implementing Technical and Science Support Services (TSSS) in the Republic of Rwanda under PEPFAR Apply for CDC RFA GH15 1570 Funding Number: CDC RFA GH15 1570 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $12,078,648 |
| Pre Symptomatic Profiles of Chronic Lung Disease(s) from Retrospective Cohorts (R21) Apply for RFA HL 15 025 Funding Number: RFA HL 15 025 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| The Midlife in the United States Study (U19) Apply for PAR 14 356 Funding Number: PAR 14 356 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening the Capacity of the Republican Blood Center to Scale Up Blood Safety Program in the Kyrgyzstan Republic under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CC RFA GH15 1512 Funding Number: CC RFA GH15 1512 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Strengthening the Capacity of the Republican Blood Center to Scale Up Blood Safety Program in Tajikistan (TJ) under the President Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1513 Funding Number: CDC RFA GH15 1513 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Strengthening HIV Clinical Services in the Republic of Rwanda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1567 Funding Number: CDC RFA GH15 1567 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $30,000,000 |
| Building Sustainable Capacity of the Ministry of Home Affairs to Address HIV and TB Prevention, Care and Treatment in Zambian Prisons and Respond to Child Sexual Abuse and Sexual Gender Based Violence in the Republic of Zambia under the Presidents Em Apply for CDC RFA GH15 1601 Funding Number: CDC RFA GH15 1601 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Definition of Resilience and Pre Symptomatic Disease in Lung Health and Disease (R01) Apply for RFA HL 15 024 Funding Number: RFA HL 15 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technical Assistance to Support the Implementation and Evaluation of HIV/AIDS Prevention, Care, Treatment, and Support Activities for Mothers, Children, and Families under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1531 Funding Number: CDC RFA GH15 1531 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $6,000,000 |
| Strengthening Blood Transfusion Services in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1559 Funding Number: CDC RFA GH15 1559 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Regional Consortia for High Resolution Cryoelectron Microscopy (U24) Apply for RFA GM 16 001 Funding Number: RFA GM 16 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ensuring Reliable and Equitable Access to PMTCT Services for Key Populations in the Republic of Mali under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1605 Funding Number: CDC RFA GH15 1605 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Biology of the Temporomandibular Joint in Health and Disease (R01) Apply for PA 14 358 Funding Number: PA 14 358 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthen the Capacity of the Republic of Malis National Institute for Public Health Research (INRSP) to Implement Laboratory Based Activities and Research in Support of STI/HIV Prevention and Care Services under the Presidents Emergency Plan for AI Apply for CDC RFA GH15 1606 Funding Number: CDC RFA GH15 1606 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Biology of the Temporomandibular Joint in Health and Disease (R21) Apply for PA 14 359 Funding Number: PA 14 359 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Support the Ministry of Health (MOH) to Scale up and Improve HIV/AIDS Prevention, Care, and Treatment Services in the Kingdom of Lesotho under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1547 Funding Number: CDC RFA GH15 1547 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Zambia DISCOVER H Apply for 611 DRAFT PROGRAM DESCRIPTION 001 Funding Number: 611 DRAFT PROGRAM DESCRIPTION 001 Agency: Zambia USAID Lusaka Category: Health Funding Amount: $60,000,000 |
| R40 Maternal and Child Health Research Program (MCHR) Apply for HRSA 15 062 Funding Number: HRSA 15 062 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| R40 Maternal and Child Health Research Program (SDAS) Apply for HRSA 15 077 Funding Number: HRSA 15 077 Agency: Health Resources and Services Administration Category: Health Funding Amount: $100,000 |
| Service Area Competition Apply for HRSA 15 014 Funding Number: HRSA 15 014 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1588", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.